Conditions: Allergy
Keywords: Sublingual immunotherapy Grass pollen tablet Allergic rhinoconjunctivitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 278
Healthy volunteers: no

Brief summary:
A phase III study to evaluate the efficacy and safety of SLIT for grass pollen allergens compared with placebo for reduction of symptoms and rescue medication usage in children.

Detailed description:

Arms:
arm 1: 300 IR grass pollen allergen extract tablet arm 2: Placebo tablet

Interventions: intervention 1: 300 IR grass pollen allergen extract tablet intervention 2: Placebo tablet
Intervention descriptions: intervention 1: One sublingual tablet daily during 4 months before pollen season and during pollen season intervention 2: One sublingual tablet daily during 4 months before pollen season and during pollen season

Protocol document: